RT Journal Article SR Electronic T1 Chemotherapy and non-small-cell lung cancer JF Drug and Therapeutics Bulletin JO Drug Ther Bull FD BMJ Publishing Group Ltd SP 9 OP 11 DO 10.1136/dtb.2002.4029 VO 40 IS 2 YR 2002 UL http://dtb.bmj.com/content/40/2/9.abstract AB Relevant BNF section: 8.1Around 34,000 people in the UK die from lung cancer each year.1 Over 75% of patients with the disease have non-small-cell lung cancer (NSCLC). Here, we discuss the role of chemotherapy in the management of NSCLC, a treatment that some medical oncologists estimate would benefit 50% of patients with NSCLC,2 but which is given to fewer than 10%.3